BlackRock Health Sciences Trust (NYSE:BME) Stock Passes Below 200-Day Moving Average – Time to Sell?

BlackRock Health Sciences Trust (NYSE:BME)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $40.52 and traded as low as $39.27. BlackRock Health Sciences Trust shares last traded at $39.6150, with a volume of 63,351 shares changing hands.

BlackRock Health Sciences Trust Trading Up 0.1%

The company’s 50-day moving average price is $39.19 and its two-hundred day moving average price is $40.53.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be given a $0.2621 dividend. This represents a c) dividend on an annualized basis and a yield of 7.9%. The ex-dividend date is Monday, June 15th.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

A number of large investors have recently added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. raised its position in BlackRock Health Sciences Trust by 285,436.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock worth $166,414,000 after purchasing an additional 4,044,638 shares during the period. 1607 Capital Partners LLC increased its position in shares of BlackRock Health Sciences Trust by 49.5% in the fourth quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock valued at $9,429,000 after acquiring an additional 75,958 shares during the period. Invesco Ltd. increased its position in shares of BlackRock Health Sciences Trust by 7.6% in the third quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock valued at $8,085,000 after acquiring an additional 15,381 shares during the period. Bank of America Corp DE increased its position in shares of BlackRock Health Sciences Trust by 18.8% in the third quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock valued at $8,057,000 after acquiring an additional 34,218 shares during the period. Finally, Royal Bank of Canada increased its position in shares of BlackRock Health Sciences Trust by 13.0% in the fourth quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock valued at $6,600,000 after acquiring an additional 18,442 shares during the period.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.